Diagnos Laboratorium Utama Tbk. vs Jaya Konstruksi Manggala Pratama Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp226 (market cap 308B, 21.3K 24h volume), while Jaya Konstruksi Manggala Pratama Tbk trades at Rp68 (market cap 1.09T, 21K 24h volume). The key difference: Jaya Konstruksi Manggala Pratama Tbk is far larger — about 3.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (21.3K versus 21K). Which is the better fit depends on your goals.
| DGNS | JKON | |
|---|---|---|
Market Cap | 308B | 1.09T |
Volume | 21.3K | 21K |
Lot | 213 | 210 |
Turnover | 4.86M | 1.43M |
Average Price | 228.07 | 68 |
Value | 4.86M | 1.43M |
Indicative Equilibrium Price | 230 | 68 |
Indicative Equilibrium Volume | 110 | 209 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.
Read more on JKON →